Robin L. Thurmond

Robin L. Thurmond

Auto-generated profile, based on publicly available information

Robin L. Thurmond

Janssen Research & Development, LLC, La Jolla, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
RTRobin L. Thurmond
Robin L. Thurmond
EGErwin W. Gelfand
Erwin W. Gelfand
PDPaul J. Dunford
Paul J. Dunford

1 April 2004 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
RTRobin L. Thurmond
Robin L. Thurmond
PDPragnya J. Desai
Pragnya J. Desai
PDPaul J. Dunford
Paul J. Dunford
WFWai-Ping Fung-Leung
Wai-Ping Fung-Leung
CHClaudia L. Hofstra
Claudia L. Hofstra
LKLars Karlsson
Lars Karlsson
Histamine mediates its physiological function through binding to four known histamine receptors. Here, we describe the first selective antagonist of the histamine H4 receptor, the newest member of the histamine receptor family, and provide evidence that such antagonists have anti-inflammatory activity in vivo. 1-[(5-chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine (JNJ 7777120) has a Ki of 4.5 nM versus the human receptor and a pA2 of 8.1. It is equipotent against the human, mouse, and rat receptors. It exhibits at least 1000-fold selectivity over H1, H2, or H3 receptors and has no cross-reactivity against 50 other targets. This compound has an oral bioavailability of ∼30% in rats and 100% in dogs, with a half-life of ∼3 h in both species. JNJ 7777120 blocks histamine-induced chemotaxis and calcium influx in mouse bone marrow-derived mast cells. In addition, it can block the histamine-induced migration of tracheal mast cells from the connective tissue toward the epithelium in mice. JNJ 7777120 significantly blocks neutrophil infiltration in a mouse zymosan-induced peritonitis model. This model is reported to be mast cell-dependent, which suggests that the compound effect may be mediated by mast cells. These results indicate that the histamine H4 receptor plays a role in the inflammatory process. Selective H4 receptor antagonists like JNJ 7777120 may have the potential to be useful in treating inflammation in humans.

1 January 2007 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
PDPaul J. Dunford
Paul J. Dunford
KWKacy N. Williams
Kacy N. Williams
PDPragnya J. Desai
Pragnya J. Desai
LKLars Karlsson
Lars Karlsson
DMDaniel McQueen
Daniel McQueen
RTRobin L. Thurmond
Robin L. Thurmond

1 May 2004 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
PLPing Ling
Ping Ling
KNKaren Ngo
Karen Ngo
SNSteven Nguyen
Steven Nguyen
RTRobin L Thurmond
Robin L Thurmond
JEJames P Edwards
James P Edwards
WFWai‐Ping Fung‐Leung
Wai‐Ping Fung‐Leung

27 April 2002 in Biochemistry
Verified
Journal Article
Closed access
ABAna Vitória Botelho
Ana Vitória Botelho
NGNicholas J. Gibson
Nicholas J. Gibson
RTRobin L. Thurmond
Robin L. Thurmond
#W# Yin Wang
# Yin Wang
MBMichael F. Brown
Michael F. Brown

1 April 2010 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JCJeffery M. Cowden
Jeffery M. Cowden
MZMai Zhang
Mai Zhang
PDPaul J. Dunford
Paul J. Dunford
RTRobin L. Thurmond
Robin L. Thurmond